2013
DOI: 10.1128/aac.02403-12
|View full text |Cite
|
Sign up to set email alerts
|

Epidemiology of Antituberculosis Drug Resistance in Saudi Arabia: Findings of the First National Survey

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

16
57
5
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 52 publications
(79 citation statements)
references
References 13 publications
16
57
5
1
Order By: Relevance
“…For Saudi Arabia, WHO estimated that 1.4%-2.4% of new TB cases and nearly 10.8% of previously treated TB cases were MDR-TB [1]. Data retrieved from published studies of Saudi Arabia demonstrated that the pattern of resistance and prevalence rate of MDR-TB in last 10 years was 4.3% of the total infected population (Table 2); however, earlier studies reported ~5.5% MDR-TB before 2000 [16] and 4% more recently [4]. There exists a strong proof-based opinion that the present status of MDR-TB in Saudi Arabia is a result of historic clones of tubercle bacilli undergoing active circulation, and also of the huge migration of people from TB-endemic countries.…”
Section: Discussionmentioning
confidence: 87%
See 4 more Smart Citations
“…For Saudi Arabia, WHO estimated that 1.4%-2.4% of new TB cases and nearly 10.8% of previously treated TB cases were MDR-TB [1]. Data retrieved from published studies of Saudi Arabia demonstrated that the pattern of resistance and prevalence rate of MDR-TB in last 10 years was 4.3% of the total infected population (Table 2); however, earlier studies reported ~5.5% MDR-TB before 2000 [16] and 4% more recently [4]. There exists a strong proof-based opinion that the present status of MDR-TB in Saudi Arabia is a result of historic clones of tubercle bacilli undergoing active circulation, and also of the huge migration of people from TB-endemic countries.…”
Section: Discussionmentioning
confidence: 87%
“…A few small-scale studies were conducted in Saudi Arabia and reported that proportions of resistance to any first-line drugs were in the range of 14% to 20%, and for MDR-TB were in the range of 1% to 44% [4,10]. These findings must be treated with full caution, as these studies were not representative of the entire country, and most were retrospective analyses of laboratory results collected from hospitals, medical colleges, and primary healthcare centers.…”
Section: Introductionmentioning
confidence: 86%
See 3 more Smart Citations